Scimeca, Giovanni
Krishnathasan, Darsiya
Rashedi, Sina
Lan, Zhou
Sato, Alyssa
Hamade, Nada
Bejjani, Antoine
Khairani, Candrika D.
Davies, Julia
Porio, Nicole
Assi, Ali A.
Armero, Andre
Tristani, Anthony
Ortiz-Rios, Marcos D.
Nauffal, Victor
Almarzooq, Zaid
Wei, Eric
Zuluaga-Sánchez, Valeria
Zarghami, Mehrdad
Achanta, Aditya
Jesudasen, Sirus J.
Tiu, Bruce
Merli, Geno J.
Leiva, Orly
Fanikos, John
Sharma, Aditya
Rizzo, Samantha
Pfeferman, Mariana B.
Morrison, Ruth B.
Vishnevsky, Alec
Hsia, Judith
Nehler, Mark R.
Welker, James
Bonaca, Marc P.
Carroll, Brett
Goldhaber, Samuel Z.
Campia, Umberto
Bikdeli, Behnood
Piazza, Gregory
Article History
Accepted: 13 February 2025
First Online: 10 March 2025
Declarations
:
: Outside the submitted work, Dr. Bikdeli is supported by a Career Development Award from the American Heart Association and VIVA Physicians (#938814). Dr. Bikdeli was supported by the Scott Schoen and Nancy Adams IGNITE Award and is supported by the Mary Ann Tynan Research Scientist award from the Mary Horrigan Connors Center for Women’s Health and Gender Biology at Brigham and Women’s Hospital, and the Heart and Vascular Center Junior Faculty Award from Brigham and Women’s Hospital. Dr. Bikdeli reports that he was a consulting expert, on behalf of the plaintiff, for litigation related to two specific brand models of IVC filters. Dr. Bikdeli has not been involved in the litigation in 2022–2024 nor has he received any compensation in 2022–2024. Dr. Bikdeli reports that he is a member of the Medical Advisory Board for the North American Thrombosis Forum, and serves in the Data Safety and Monitory Board of the NAIL-IT trial funded by the National Heart, Lung, and Blood Institute, and Translational Sciences. Dr. Bikdeli is a collaborating consultant with the International Consulting Associates and the US Food and Drug Administration in a study to generate knowledge about utilization, predictors, retrieval, and safety of IVC filters. Dr. Bikdeli receives compensation as an Associated Editor for the New England Journal of Medicine Journal Watch Cardiology, as an Associate Editor for Thrombosis Research, and as an Executive Associate Editor for JACC, and is a Section Editor for Thrombosis and Haemostasis (no compensation). Dr. Piazza receives grant/research support paid to his institution from BMS/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Esperion, and NIH 1R01HL164717-01 and consultant fees/honoraria from BSC, Amgen, BCRI, PERC, NAMSA, BMS, Janssen, and Regeneron.
: The authors declare no competing interests.